IBER.U
Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant
IBER.U
IBER.U
Delisted
IBER.U was delisted on the 1st of March, 2023.
34 hedge funds and large institutions have $52.4M invested in Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
96% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 26
Holders
34
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$308K | |
| 2 | +$267K | |
| 3 | +$109K | |
| 4 |
Jane Street
New York
|
+$65.7K |
| 5 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$10.1K |
Top Sellers
| 1 | -$5.5M | |
| 2 | -$4.93M | |
| 3 | -$4.88M | |
| 4 |
LA
Linden Advisors
New York
|
-$4.44M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$4.44M |